Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125991942 | 12599194 | 2 | F | 2012 | 20160804 | 20160727 | 20160816 | EXP | CA-JNJFOC-20160718995 | JANSSEN | 6.00 | DEC | A | F | Y | 0.00000 | 20160816 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125991942 | 12599194 | 1 | PS | INFLIXIMAB | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | TOOK FOR 5 YEARS | U | U | UNKNOWN | 103772 | LYOPHILIZED POWDER | ||||||
125991942 | 12599194 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | 40 | MG | UNSPECIFIED | |||||||
125991942 | 12599194 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 0 | UNSPECIFIED | |||||||||
125991942 | 12599194 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | TOOK FOR 5 MONTHS | U | 0 | UNSPECIFIED | ||||||||
125991942 | 12599194 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | U | 0 | 428 | MG | UNSPECIFIED | |||||||
125991942 | 12599194 | 6 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
125991942 | 12599194 | 7 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 0 | 400 | MG | UNSPECIFIED | QD | |||||||
125991942 | 12599194 | 8 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 0 | 1500 | MG | UNSPECIFIED | BID | |||||||
125991942 | 12599194 | 9 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125991942 | 12599194 | 10 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125991942 | 12599194 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 0 | 20 | MG | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125991942 | 12599194 | 1 | Rheumatoid arthritis |
125991942 | 12599194 | 2 | Product used for unknown indication |
125991942 | 12599194 | 3 | Product used for unknown indication |
125991942 | 12599194 | 4 | Product used for unknown indication |
125991942 | 12599194 | 5 | Product used for unknown indication |
125991942 | 12599194 | 8 | Rheumatoid arthritis |
125991942 | 12599194 | 9 | Pain |
125991942 | 12599194 | 10 | Blood pressure measurement |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125991942 | 12599194 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125991942 | 12599194 | Cerebrovascular accident | |
125991942 | 12599194 | Drug ineffective | |
125991942 | 12599194 | Hand deformity | |
125991942 | 12599194 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125991942 | 12599194 | 1 | 2011 | 0 | ||
125991942 | 12599194 | 2 | 20150924 | 2016 | 0 | |
125991942 | 12599194 | 3 | 20160714 | 0 | ||
125991942 | 12599194 | 5 | 20131202 | 20140428 | 0 | |
125991942 | 12599194 | 6 | 20150913 | 0 | ||
125991942 | 12599194 | 7 | 2005 | 0 | ||
125991942 | 12599194 | 8 | 2005 | 0 | ||
125991942 | 12599194 | 11 | 2005 | 2015 | 0 |